Can You Pass Severe Sickle Cell Disease if You Have S-HPFH?
At a Glance
Yes, a person with S-HPFH can pass severe sickle cell disease to their child, but only if their partner also carries the sickle cell trait or another hemoglobin trait. Comprehensive genetic screening for your partner is essential to understand your exact risks before having a child.
In this answer
4 sections
Yes, a person with S-HPFH can pass severe sickle cell disease to their child. However, this only happens if their partner also carries the sickle cell gene or another hemoglobin trait. The risk of your child having severe sickle cell disease depends entirely on your partner’s genetic status [1][2].
Understanding the Genetics of S-HPFH
To understand how this works, it helps to look at the genes involved. S-HPFH is what doctors call a compound heterozygous condition [1][3]. This simply means you inherited two different hemoglobin genes, one from each of your parents:
When you have a child, you do not pass on your exact condition. Instead, you will pass on only one of these two genes [4]. For every pregnancy, you have a 50% chance of passing on the sickle cell gene, and a 50% chance of passing on the HPFH gene.
Why Partner Testing is Crucial
Because you carry one sickle cell gene, your partner’s genetics are the deciding factor in whether your child will have severe sickle cell disease [5]. This is why partner testing is an absolutely essential part of family planning.
Depending on your partner’s test results, here is what could happen:
- If your partner has normal hemoglobin (HbAA): Your child cannot have severe sickle cell disease. They will either inherit the sickle cell trait (if you pass your S gene) or the HPFH trait (if you pass your HPFH gene). Neither of these traits causes severe disease, though your child will need to know their status for their own family planning in the future.
- If your partner has the sickle cell trait (HbAS): There is a risk. For each pregnancy, there are four possible outcomes based on which genes are passed down:
- 25% chance of HbSS (severe sickle cell anemia) - inheriting your S gene and your partner’s S gene [5][6].
- 25% chance of S-HPFH (your mild condition) - inheriting your HPFH gene and your partner’s S gene.
- 25% chance of sickle cell trait (HbAS) - inheriting your S gene and your partner’s normal A gene.
- 25% chance of HPFH trait - inheriting your HPFH gene and your partner’s normal A gene.
- If your partner has another hemoglobin trait: If your partner carries a different trait, such as hemoglobin C or beta-thalassemia, your child could also be born with other forms of sickle cell disease if they inherit your sickle cell gene [5][7].
Here is a visual breakdown of the genetic outcomes if your partner has the sickle cell trait (HbAS):
| Your Passed Gene | Partner’s Passed Gene | Child’s Inheritance | Child’s Condition |
|---|---|---|---|
| S | S | HbSS | Severe Sickle Cell Anemia |
| HPFH | S | S-HPFH | Mild Sickle Cell Syndrome |
| S | A | HbAS | Sickle Cell Trait (Carrier) |
| HPFH | A | HPFH Trait | HPFH Trait (Carrier) |
Why HbSS is More Severe Than S-HPFH
You might wonder why a child with HbSS would have a severe disease when your own S-HPFH is mild.
Your condition is usually very mild because the HPFH gene tells your body to keep producing high levels of fetal hemoglobin well into adulthood [1][8]. This fetal hemoglobin acts as a powerful shield, preventing your red blood cells from sickling and protecting you from severe symptoms [9][10].
If your child inherits two sickle cell genes (HbSS), it means they inherited your sickle cell gene rather than your HPFH gene [4]. Without that protective HPFH gene [11], their body will not produce the high levels of fetal hemoglobin needed to stop the sickling process, leading to the severe symptoms associated with classic sickle cell anemia [1].
Next Steps for Family Planning
If you have S-HPFH and are planning to have a child, here are the most important steps you can take:
- Request comprehensive screening for your partner: Your partner should undergo a specialized hemoglobin blood test (such as hemoglobin electrophoresis or high-performance liquid chromatography, often abbreviated as HPLC) before you try to conceive [12]. A routine complete blood count (CBC) is not detailed enough to detect all traits.
- Meet with a genetic counselor: A genetic professional can review your specific molecular diagnosis, as there are different types of HPFH mutations [7]. They can explain your exact risks and help you navigate your family planning options safely [12].
- Explore reproductive options: If your partner is found to be a carrier of a hemoglobin trait, a genetic counselor can also discuss advanced reproductive options [7]. For example, in vitro fertilization (IVF) with preimplantation genetic testing (PGT) allows doctors to test embryos for sickle cell disease before pregnancy, offering a way to prevent passing on the severe condition.
Common questions in this guide
Can someone with S-HPFH have a child with severe sickle cell disease?
Why is partner testing important if I have S-HPFH?
What kind of blood test does my partner need for sickle cell screening?
Why are my S-HPFH symptoms mild while classic sickle cell is severe?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Could you review my specific S-HPFH genetic test results to confirm exactly which HPFH mutation I have, and how it might impact my child?
- 2.What specific wording should my partner use when asking their doctor for comprehensive hemoglobin screening rather than just a standard blood test?
- 3.If my partner's test comes back positive for a hemoglobin trait, can you refer us to a specialized genetic counselor with experience in sickle cell family planning?
- 4.Are there advanced reproductive options, like IVF with preimplantation genetic testing, available through our current healthcare network if we are at high risk?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
Sickle cell disease severity: an introduction.
Pace BS, Goodman SR
Experimental biology and medicine (Maywood, N.J.) 2016; (241(7)):677-8 doi:10.1177/1535370216641880.
PMID: 27190296 - 2
The Natural History of Hb S/Hereditary Persistence of Fetal Hemoglobin in 13 Children from the State of Minas Gerais, Brazil.
Belisário AR, Sales RR, Silva CM, et al.
Hemoglobin 2016; (40(3)):215-9 doi:10.3109/03630269.2016.1149076.
PMID: 27117574 - 3
Microcytosis Merits Evaluation: A Case Report of Hemoglobin S With Hereditary Persistence of Fetal Hemoglobin (HbS-HPFH Syndrome).
Daniel CE, Bejjani A
Cureus 2025; (17(2)):e78827 doi:10.7759/cureus.78827.
PMID: 40084327 - 4
Fetal hemoglobin induction in sickle erythroid progenitors using a synthetic zinc finger DNA-binding domain.
Li B, Zhu X, Hossain MA, et al.
Haematologica 2018; (103(9)):e384-e387 doi:10.3324/haematol.2017.185967.
PMID: 29622657 - 5
Assessment of Hemoglobin Variants in Patients Receiving Health Care at the Ho Teaching Hospital: A Three-Year Retrospective Study.
Awaitey DK, Akorsu EE, Allotey EA, et al.
Advances in hematology 2020; (2020()):7369731 doi:10.1155/2020/7369731.
PMID: 32256599 - 6
The evolving treatment landscape for children with sickle cell disease.
Jacob SA, Talati R, Kanter J
The Lancet. Child & adolescent health 2023; (7(11)):797-808 doi:10.1016/S2352-4642(23)00201-8.
PMID: 37858508 - 7
Genetic research and clinical analysis of deletional Chinese Gγ+(Aγδβ)0 -thalassemia and Southeast Asian HPFH in South China.
Wu Y, Yao Q, Zhong M, et al.
Annals of hematology 2020; (99(12)):2747-2753 doi:10.1007/s00277-020-04252-7.
PMID: 32930850 - 8
β-Hemoglobinopathies: The Test Bench for Genome Editing-Based Therapeutic Strategies.
Barbarani G, Łabedz A, Ronchi AE
Frontiers in genome editing 2020; (2()):571239 doi:10.3389/fgeed.2020.571239.
PMID: 34713219 - 9
Sickle cell disease in the era of precision medicine: looking to the future.
Steinberg MH, Kumar S, Murphy GJ, Vanuytsel K
Expert review of precision medicine and drug development 2019; (4(6)):357-367 doi:10.1080/23808993.2019.1688658.
PMID: 33015364 - 10
Inhibition of LSD1 by small molecule inhibitors stimulates fetal hemoglobin synthesis.
Le CQ, Myers G, Habara A, et al.
Blood 2019; (133(22)):2455-2459 doi:10.1182/blood.2018892737.
PMID: 30992270 - 11
Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes.
Steinberg MH
Journal of clinical medicine 2020; (9(11)) doi:10.3390/jcm9113782.
PMID: 33238542 - 12
Molecular spectrum and carrier frequency of deletional hereditary persistence of fetal hemoglobin and delta-beta thalassemia in Malaysia.
Abdul Hamid FS, Md Noor S, Lai MI, et al.
Blood research 2025; (60(1)):51 doi:10.1007/s44313-025-00100-7.
PMID: 41023561
This information about S-HPFH inheritance is for educational purposes only and does not replace professional medical advice. Always consult a genetic counselor or hematologist for family planning guidance specific to your genetics.
Get notified when new evidence is published on Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.